New AAD guidelines - management of psoriasis with topical therapy and alternative medicine modalities
Psoriasis is a chronic, inflammatory, multisystem disease which affects up to 3.2% of the U.S population. This guideline addresses important clinical questions that arise in psoriasis management and care and provides recommendations based on the available evidence. The treatment of psoriasis with topical agents and with alternative medicine (AM) will be reviewed, emphasizing treatment recommendations and the role of dermatologists in monitoring and educating patients regarding benefits as well as risks that may be associated. This guideline will also address the severity assessment methods of psoriasis in adults.
Clinical guidelines for psoriasis, topical agents, severity assessment, alternative medicine (AM), dermatology guidelines, psoriasis, skin disease
Read the guidelines HERE
© 2020 by the American Academy of Dermatology, Inc. Published by Elsevier Inc.